GO ID | GO:0001822 |
Ontology | BP |
GO Term | kidney development |
Definition | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
10018 |
O43521 |
chr2: 111,119,378-111,168,447 |
TCF21 |
transcription factor 21 |
6943 |
O43680 |
chr6: 133,889,138-133,895,553 |
ALDH1A2 |
aldehyde dehydrogenase 1 family member A2 |
8854 |
O94788 |
chr15: 57,953,424-58,497,866 |
CA2 |
carbonic anhydrase II |
760 |
P00918 |
chr8: 85,463,852-85,481,493 |
ASS1 |
argininosuccinate synthase 1 |
445 |
P00966 |
chr9: 130,444,929-130,501,274 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
183 |
P01019 |
chr1: 230,702,523-230,714,297 |
DCN |
decorin |
1634 |
P07585 |
chr12: 91,140,484-91,183,123 |
MME |
membrane metallo-endopeptidase |
4311 |
P08473 |
chr3: 155,024,124-155,183,729 |
GLI2 |
GLI family zinc finger 2 |
2736 |
P10070 |
chr2: 120,735,623-120,992,653 |
ODC1 |
ornithine decarboxylase 1 |
4953 |
P11926 |
chr2: 10,439,968-10,448,504 |
BMP4 |
bone morphogenetic protein 4 |
652 |
P12644 |
chr14: 53,949,736-53,958,761 |
ACE |
angiotensin I converting enzyme |
1636 |
P12821 |
chr17: 63,477,061-63,498,380 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
WT1 |
Wilms tumor 1 |
7490 |
P19544 |
chr11: 32,387,775-32,435,630 |
BMP6 |
bone morphogenetic protein 6 |
654 |
P22004 |
chr6: 7,726,797-7,881,422 |
MPST |
mercaptopyruvate sulfurtransferase |
4357 |
P25325 |
chr22: 37,019,635-37,029,822 |
AGTR1 |
angiotensin II receptor, type 1 |
185 |
P30556 |
chr3: 148,697,784-148,743,008 |
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
5176 |
P36955 |
chr17: 1,761,959-1,777,574 |
CENPF |
centromere protein F |
1063 |
P49454 |
chr1: 214,603,195-214,664,588 |
TMED10 |
transmembrane p24 trafficking protein 10 |
10972 |
P49755 |
chr14: 75,131,470-75,176,631 |
CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
1028 |
P49918 |
chr11: 2,883,213-2,885,881 |
HRSP12 |
heat-responsive protein 12 |
10247 |
P52758 |
chr8: 98,102,344-98,117,241 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
5310 |
P98161 |
chr16: 2,088,710-2,135,898 |
PPAT |
phosphoribosyl pyrophosphate amidotransferase |
5471 |
Q06203 |
chr4: 56,393,362-56,435,615 |
PAX8 |
paired box 8 |
7849 |
Q06710 |
chr2: 113,215,997-113,278,950 |
BAX |
BCL2-associated X protein |
581 |
Q07812 |
chr19: 48,954,815-48,961,798 |
HYAL2 |
hyaluronoglucosaminidase 2 |
8692 |
Q12891 |
chr3: 50,317,790-50,322,906 |
ACVR2B |
activin A receptor type IIB |
93 |
Q13705 |
chr3: 38,453,851-38,493,142 |
ARID5B |
AT-rich interaction domain 5B |
84159 |
Q14865 |
chr10: 61,901,300-62,096,944 |
RGN |
regucalcin |
9104 |
Q15493 |
chrX: 47,078,355-47,093,314 |
TNS2 |
tensin 2 |
23371 |
Q63HR2 |
chr12: 53,046,969-53,064,372 |
JMJD6 |
jumonji domain containing 6 |
23210 |
Q6NYC1 |
chr17: 76,712,832-76,726,799 |
NPHP3 |
nephronophthisis 3 (adolescent) |
27031 |
Q7Z494 |
chr3: 132,680,609-132,722,442 |
SULF2 |
sulfatase 2 |
55959 |
Q8IWU5 |
chr20: 47,656,348-47,786,616 |
SULF1 |
sulfatase 1 |
23213 |
Q8IWU6 |
chr8: 69,466,624-69,660,915 |
PCSK9 |
proprotein convertase subtilisin/kexin type 9 |
255738 |
Q8NBP7 |
chr1: 55,039,548-55,064,852 |
PROX1 |
prospero homeobox 1 |
5629 |
Q92786 |
chr1: 213,983,181-214,041,502 |
HAS2 |
hyaluronan synthase 2 |
3037 |
Q92819 |
chr8: 121,612,116-121,641,390 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
5125 |
Q92824 |
chr9: 75,890,644-76,362,339 |
PYGO2 |
pygopus family PHD finger 2 |
90780 |
Q9BRQ0 |
chr1: 154,957,026-154,963,853 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
9510 |
Q9UHI8 |
chr21: 26,835,747-26,845,409 |